4 results match your criteria: "France. Electronic address: cyrille.vaillend@universite-paris-saclay.fr.[Affiliation]"

Duchenne muscular dystrophy (DMD) is associated with a range of cognitive and behavioral problems. Brain-related comorbidities show clinical heterogeneity depending on the position of the mutation within the multi-promoter dystrophin (DMD) gene, likely due to the differential impact of mutations on the expression of distinct brain dystrophins. A deficiency of the full-length brain dystrophin, Dp427, has been associated with enhanced stress reactivity, characterized by abnormal fear responses in both patients and mdx mouse model.

View Article and Find Full Text PDF

The unconditioned fear response in vertebrates deficient in dystrophin.

Prog Neurobiol

April 2024

Institute for Physical Activity and Nutrition, School of Exercise and Nutrition Sciences, Deakin University, Geelong, Australia; School of Biological Sciences, University of Canterbury, Christchurch 8041, New Zealand; Department of Medicine, University of Otago, Christchurch 8014, New Zealand. Electronic address:

Dystrophin loss due to mutations in the Duchenne muscular dystrophy (DMD) gene is associated with a wide spectrum of neurocognitive comorbidities, including an aberrant unconditioned fear response to stressful/threat stimuli. Dystrophin-deficient animal models of DMD demonstrate enhanced stress reactivity that manifests as sustained periods of immobility. When the threat is repetitive or severe in nature, dystrophinopathy phenotypes can be exacerbated and even cause sudden death.

View Article and Find Full Text PDF

Duchenne muscular dystrophy (DMD) is caused by X-linked inherited or de novo DMD gene mutations predominantly affecting males who develop early-onset muscle degeneration, severely affecting their quality of life and leading to reduced life expectancy. DMD patients may also develop proliferative retinopathy, cataract, ERG abnormalities, altered contrast sensitivity, color vision losses, and elevated flash detection thresholds during dark adaptation. Depending on the position of the genetic alteration in the large DMD gene, it is associated with a lack of the full-length dystrophin protein possibly with an additional loss of one or several other dystrophins, which are normally transcribed from internal promoters in retina and crystalline lens.

View Article and Find Full Text PDF
Article Synopsis
  • The mdx52 mouse model of Duchenne muscular dystrophy (DMD) lacks exon 52 of the DMD gene, leading to the absence of certain dystrophin proteins while preserving Dp71.
  • Functional analysis of the mouse's retinal physiology through electroretinogram (ERG) tests revealed reduced and delayed responses in dark-adapted conditions and diminished amplitudes in light-adapted conditions.
  • Behavioral tests showed that while mdx52 mice performed similarly to controls at full contrast, they had significantly reduced contrast sensitivity at lower contrast levels, implicating issues with photoreceptor-to-bipolar cell transmission and making the model valuable for DMD research.
View Article and Find Full Text PDF